Comparing and Contrasting the Approach to Advance Care Planning in Multiple Sclerosis

2018 ◽  
pp. 161-164
Author(s):  
Aynharan Sinnarajah
2021 ◽  
Vol 17 (Sup3) ◽  
pp. S20-S22
Author(s):  
Lorraine Petersen

Multiple sclerosis (MS) has a long illness trajectory punctuated by serious acute events, with a later stage that is often accompanied by cognitive impairment. There is ample time for advance care planning (ACP) discussions. While there is much to be learned about the optimal way to approach ACP for people living with MS, it is possible to approach these discussions sensitively at all stages of the condition. However, as such voluntary discussions currently lie outside usual practice, people living with MS are denied the opportunities to consider the effect future medical treatments may have on their quality and length of life. How can clinicians assist in planning for a ‘good life’ and a ‘good death’?


BMJ Open ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. e052012
Author(s):  
Ludovica De Panfilis ◽  
Simone Veronese ◽  
Michela Bruzzone ◽  
Marta Cascioli ◽  
Alberto Gajofatto ◽  
...  

IntroductionMultiple sclerosis (MS) is the most common cause of progressive neurological disability in young adults. The use of advance care planning (ACP) for people with progressive MS (pwPMS) remains limited. The ConCure-SM project aims to assess the effectiveness of a structured ACP intervention for pwPMS. The intervention consists of a training programme on ACP for healthcare professionals caring for pwPMS, and a booklet to be used during the ACP conversation. Herein, we describe the first two project phases.MethodsIn phase 1 we translated and adapted, to the Italian legislation and MS context, the ACP booklet of the National ACP Programme for New Zealand. Acceptability, comprehensibility and usefulness of the booklet were assessed via 13 personal cognitive interviews with pwPMS and significant others (SOs), and one health professional focus group. Based on these findings, we will revise the booklet. In phase 2 we will conduct a single-arm pilot/feasibility trial with nested qualitative study. Participants will be 40 pwPMS, their SOs, health professionals from six MS and rehabilitation centres in Italy. In the 6 months following the ACP conversation, we will assess completion of an advance care plan document (primary outcome), as well as safety of the intervention. Secondary outcomes will be a range of measures to capture the full process of ACP; patient-carer congruence in treatment preferences; quality of patient-clinician communication and caregiver burden. A qualitative process evaluation will help understand the factors likely to influence future implementation and scalability of the intervention.Ethics and disseminationThe project is coleaded by a neurologist and a bioethicist. Phase 1 has received ethical approvals from each participating centre, while phase 2 will be submitted to the centres in May 2021. Findings from both phases will be disseminated widely through peer-reviewed publications, conferences and workshops.Trial registration numberISRCTN48527663; Pre-results.


PLoS ONE ◽  
2020 ◽  
Vol 15 (10) ◽  
pp. e0240815
Author(s):  
Laura Cottrell ◽  
Guillaume Economos ◽  
Catherine Evans ◽  
Eli Silber ◽  
Rachel Burman ◽  
...  

2021 ◽  
Vol 429 ◽  
pp. 118081
Author(s):  
Ludovica De Panfilis ◽  
Simone Veronese ◽  
Luca Ghirotto ◽  
Michela Bruzzone ◽  
Marta Cascioli ◽  
...  

2018 ◽  
Vol 75 (2) ◽  
pp. 105-111 ◽  
Author(s):  
Ralf J. Jox ◽  
Francesca Bosisio ◽  
Eve Rubli Truchard

Zusammenfassung. Die Palliative Care muss sich im Zuge des demographischen Wandels vieler Gesellschaften rund um den Globus tiefgreifend wandeln. Sie muss mehr und mehr mit der Geriatrie zusammenarbeiten und geriatrische Expertise integrieren. Eine der zentralen Herausforderungen Geriatrischer Palliative Care ist die ethisch angemessene Therapieentscheidung für Menschen, die nicht mehr urteilsfähig sind. Nachdem der bisherige Ansatz herkömmlicher Patientenverfügungen erwiesenermassen enttäuscht hat, wird aktuell, gerade auch in deutschsprachigen Ländern, das systemische Konzept des Advance Care Planning (ACP) verfolgt. In diesem Artikel wird zunächst ACP mit seinen Zielen, Elementen und Effekten vorgestellt. Sodann wird gezeigt, weshalb es für Menschen mit Demenz eines adaptierten ACP-Programms bedarf und was ein solches demenzspezifisches ACP beinhalten muss.


Praxis ◽  
2017 ◽  
Vol 106 (25) ◽  
pp. 1369-1375 ◽  
Author(s):  
Barbara Loupatatzis ◽  
Tanja Krones

Zusammenfassung. Advance Care Planning ist ein begleiteter, strukturierter Prozess, der es Patienten und ihren Angehörigen ermöglicht, sich mit ihren Einstellungen zu Leben und Sterben sowie möglichen Behandlungen für den Fall einer Urteilsunfähigkeit mit Hilfe eines ausgebildeten Beraters auseinander zu setzen. Das Konzept kombiniert die individuelle Beratung des Patienten mit einem regionalen, systemischen Ansatz, der sicherstellt, dass alle Beteiligten die verwendeten Dokumente kennen und auch in einer Notfallsituation korrekt anwenden können. Ziel ist es, die Behandlung von urteilsunfähigen Patienten besser im Sinne ihrer Wünsche und Bedürfnisse zu koordinieren und dadurch die Patientenautonomie zu stärken.


Sign in / Sign up

Export Citation Format

Share Document